Submissions from 2022
Author Correction: Neutrophil to lymphocyte ratio influences impact of steroids on efficacy of immune checkpoint inhibitors in lung cancer brain metastases, Manmeet Ahluwalia
Phase I Study of Accelerated Hypofractionated Proton Therapy and Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer, Jessika Contreras
Author Correction: Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases, Rupesh Kotecha and Manmeet Ahluwalia
Volume doubling time and radiomic features predict tumor behavior of screen-detected lung cancers, Tugce Kutuk
The Graded Prognostic Assessment (GPA) for Lung Cancer Patients with Brain Metastases: Initial Report of the Small Cell Lung Cancer GPA and Update of the Non-Small Cell Lung Cancer GPA including the Effect of Programmed Death Ligand-1 (PD-L1) and Other Prognostic Factors, Tugce Kutuk, Rupesh Kotecha, Manmeet Ahluwalia, and Minesh Mehta
Pralsetinib: Treatment of metastatic RET fusion-positive non-small cell lung cancer, Shanada Monestime
Small spot size versus large spot size: Effect on plan quality for lung cancer in pencil beam scanning proton therapy, Suresh Rana
Submissions from 2021
Author Correction: Neutrophil to lymphocyte ratio influences impact of steroids on efficacy of immune checkpoint inhibitors in lung cancer brain metastases, Manmeet Ahluwalia
Open Access
Neutrophil to lymphocyte ratio influences impact of steroids on efficacy of immune checkpoint inhibitors in lung cancer brain metastases, Manmeet Ahluwalia
Open Access
Predictors of attrition in a smoking cessation trial conducted in the lung cancer screening setting, Juan Batlle
Full Text Restricted – Available from BHSF IP or login only
Bone Metastases in Lung Cancer, Ana Cecilia Belzarena Genovese
Open Access
Case report of visual biofeedback-driven, magnetic resonance-guided single-fraction SABR in breath hold for early stage non-small-cell lung cancer, Michael Chuong, Rupesh Kotecha, Minesh Mehta, Sonia Adamson, Tino Romaguera, Matthew Hall, Diane Alvarez, Alonso Gutierrez, Vivek Mishra, Fernando De Zarraga, and Kathryn Mittauer
Full Text Restricted – Available from BHSF IP or login only
Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases, Rupesh Kotecha and Manmeet Ahluwalia
Open Access
Pralsetinib (Gavreto): Treatment of metastatic non-small-cell lung cancer in patients positive for RET fusions, Shanada Monestime
Investigating volumetric repainting to mitigate interplay effect on 4D robustly optimized lung cancer plans in pencil beam scanning proton therapy, Suresh Rana
Open Access
Systematic review and meta-analysis of lung cancer brain metastasis and primary tumor receptor expression discordance, Raees Tonse, Muni Rubens, Haley Appel, Martin Tom, Matthew Hall, Yazmin Odia, Michael McDermott, Manmeet Ahluwalia, Minesh Mehta, and Rupesh Kotecha
Systematic review and meta-analysis of PD-L1 expression discordance between primary tumor and lung cancer brain metastasis, Raees Tonse, Muni Rubens, Haley Appel, Martin Tom, Matthew Hall, Yazmin Odia, Michael McDermott, Manmeet Ahluwalia, Minesh Mehta, and Rupesh Kotecha
OTHR-07. Systematic Review and Meta-analysis of Lung Cancer Brain Metastasis and Primary Tumor PD-L1 Expression Discordance, Raees Tonse, Muni Rubens, Haley Appel, Martin Tom, Matthew Hall, Yazmin Odia, Minesh Mehta, Michael McDermott, manmeet Ahluwalia, and Rupesh Kotecha
Systemic Therapy and Radiation Therapy in Lung Cancer, Raees Tonse, Martin Tom, and Rupesh Kotecha
Full Text Restricted – Available from BHSF IP or login only
Clinical Outcomes for Plasma-Based Comprehensive Genomic Profiling Versus Standard-of-Care Tissue Testing in Advanced Non-Small Cell Lung Cancer, Miguel Villalona Calero
Submissions from 2020
The Association Between Laboratory Pretreatment Immune Parameters and Radiographic Lung Changes in Early Stage Lung Cancer Patients Undergoing Stereotactic Body Radiation Therapy, Noah Kalman
Full Text Restricted – Available from BHSF IP or login only
A Phase II Trial of Albumin-Bound Paclitaxel and Gemcitabine in Patients with Newly Diagnosed Stage IV Squamous Cell Lung Cancers, Miguel Villalona Calero
Full Text Restricted – Available from BHSF IP or login only
Submissions from 2019
Study protocol for a telephone-based smoking cessation randomized controlled trial in the lung cancer screening setting: The lung screening, tobacco, and health trial, Juan Batlle
Full Text Restricted – Available from BHSF IP or login only
Brain metastases from non-small cell lung cancer with EGFR or ALK mutations: A systematic review and meta-analysis of multidisciplinary approaches, Rupesh Kotecha
Full Text Restricted – Available from BHSF IP or login only
Management of patients with brain metastases from non-small cell lung cancer and adverse prognostic features: multi-national radiation treatment recommendations are heterogeneous, Minesh Mehta
Open Access
Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non-small Cell Lung Cancer, Miguel Villalona Calero
Full Text Restricted – Available from BHSF IP or login only
Submissions from 2018
A five-step strategy for building an LDCT lung cancer screening program, Juan Batlle, Muhammad Latif, and Ricardo Cury
Robotic resection of Stage III lung cancer: an international retrospective study, Mark Dylewski
Full Text Restricted – Available from BHSF IP or login only
The long-term survival of robotic lobectomy for non-small cell lung cancer: A multi-institutional study, Mark Dylewski
Full Text Restricted – Available from BHSF IP or login only
Brain Metastases in Lung Cancer With Targetable Mutations-Reply, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
Adaptive planning and toxicities of uniform scanning proton therapy for lung cancer patients, Suresh Rana
Open Access
Incidence, Risk Factors, and Effect on Survival of Immune-related Adverse Events in Patients With Non-Small-cell Lung Cancer, Miguel Villalona Calero
Open Access
Submissions from 2017
Robotic assisted lobectomy for locally advanced lung cancer, Mark Dylewski
Full Text Restricted – Available from BHSF IP or login only
Cost-effectiveness of prophylactic cranial irradiation with hippocampal avoidance in limited stage small cell lung cancer, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
Multi-Institutional Experience of Stereotactic Ablative Radiation Therapy for Stage I Small Cell Lung Cancer, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only
Reirradiation of recurrent node-positive non-small cell lung cancer after previous stereotactic radiotherapy for stage I disease : A multi-institutional treatment recommendation, Minesh Mehta
Full Text Restricted – Available from BHSF IP or login only